These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31426843)

  • 1. Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.
    Kim KY; Yoon M; Cho Y; Lee KH; Park S; Lee SR; Choi SY; Lee D; Yang C; Cho EH; Jeon SD; Kim SH; Kim C; Kim MG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):363. PubMed ID: 31426843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.
    Kim S; Yang JW; Kim C; Kim MG
    Oncotarget; 2016 Jun; 7(23):34643-63. PubMed ID: 27167193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function.
    Cho Y; Kim SB; Kim J; Pham AVQ; Yoon MJ; Park JH; Hwang KT; Park D; Cho Y; Kim MG; Kim C
    BMC Biol; 2020 Jun; 18(1):60. PubMed ID: 32493324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Adjuvant Influences on Preventive Anti-Metastasis Vaccine Using a Structural Epitope Derived from Membrane Type Protease PRSS14.
    Kim KY; Cho EH; Yoon M; Kim MG
    Immune Netw; 2020 Aug; 20(4):e33. PubMed ID: 32895620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers.
    Braitbard O; Roniger M; Bar-Sinai A; Rajchman D; Gross T; Abramovitch H; La Ferla M; Franceschi S; Lessi F; Naccarato AG; Mazzanti CM; Bevilacqua G; Hochman J
    Oncotarget; 2016 Apr; 7(16):21168-80. PubMed ID: 26934560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.
    Wang X; Osada T; Wang Y; Yu L; Sakakura K; Katayama A; McCarthy JB; Brufsky A; Chivukula M; Khoury T; Hsu DS; Barry WT; Lyerly HK; Clay TM; Ferrone S
    J Natl Cancer Inst; 2010 Oct; 102(19):1496-512. PubMed ID: 20852124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel humanized monoclonal antibodies against ROR1 for cancer therapy.
    Wei R; Liao X; Li J; Mu X; Ming Y; Peng Y
    Mol Cancer; 2024 Aug; 23(1):165. PubMed ID: 39138527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer.
    Hao J; Jin R; Yi Y; Jiang X; Yu J; Xu Z; Schnicker NJ; Chimenti MS; Sugg SL; Li B
    Breast Cancer Res; 2024 Jul; 26(1):119. PubMed ID: 39054536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
    Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
    BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.
    Spiridon CI; Ghetie MA; Uhr J; Marches R; Li JL; Shen GL; Vitetta ES
    Clin Cancer Res; 2002 Jun; 8(6):1720-30. PubMed ID: 12060609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers.
    Oshima T; Sato S; Kato J; Ito Y; Watanabe T; Tsuji I; Hori A; Kurokawa T; Kokubo T
    Mol Cancer; 2013 Jun; 12():60. PubMed ID: 23758976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu.
    Jasinska J; Wagner S; Radauer C; Sedivy R; Brodowicz T; Wiltschke C; Breiteneder H; Pehamberger H; Scheiner O; Wiedermann U; Zielinski CC
    Int J Cancer; 2003 Dec; 107(6):976-83. PubMed ID: 14601058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRSS14/Epithin is induced in macrophages by the IFN-γ/JAK/STAT pathway and mediates transendothelial migration.
    Lee D; Lee HS; Yang SJ; Jeong H; Kim DY; Lee SD; Oh JW; Park D; Kim MG
    Biochem Biophys Res Commun; 2011 Feb; 405(4):644-50. PubMed ID: 21295011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential.
    Kim SB; Lee D; Jeong JW; Kim C; Park D; Kim MG
    Mol Cells; 2010 Jun; 29(6):617-23. PubMed ID: 20652801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.
    Jia X; Yu F; Wang J; Iwanowycz S; Saaoud F; Wang Y; Hu J; Wang Q; Fan D
    Breast Cancer Res Treat; 2014 Nov; 148(2):291-302. PubMed ID: 25311112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Peptides Targeting Metastatic Tumor Cells as Probes for Cancer Detection and Vehicles for Therapy Delivery.
    Subramanian S; Daquinag AC; AghaAmiri S; Ghosh SC; Azhdarinia A; Kolonin MG
    Cancer Res; 2021 Nov; 81(22):5756-5764. PubMed ID: 34607842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.
    Achyut BR; Zhang H; Angara K; Mivechi NF; Arbab AS; Ko L
    Cancer Lett; 2020 Apr; 476():57-66. PubMed ID: 32061755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
    Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
    BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.